<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04222387</url>
  </required_header>
  <id_info>
    <org_study_id>CSA_2019_13</org_study_id>
    <nct_id>NCT04222387</nct_id>
  </id_info>
  <brief_title>Investigation of Potential Retinal Toxicity Associated With Hair Dye Products Containing pPD Type Aromatic Amines</brief_title>
  <acronym>CAPITOX</acronym>
  <official_title>Investigation of Potential Retinal Toxicity Associated With Hair Dye Products Containing pPD (Para-phenylenediamine) Type Aromatic Amines</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Fondation Ophtalmologique Adolphe de Rothschild</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Fondation Ophtalmologique Adolphe de Rothschild</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Hair dye products could induce minimal forms of MEKAR retinopathies (Mitogen-activated
      Extracellular signal-regulated Kinase - inhibitors associated retinopathies). These minimal
      forms of MEKAR are likely to be underdiagnosed, since the associated visual loss is usually
      mild and so this condition should be considered when patients report blurred vision. The aim
      of the study is to analyze whether in the current population that dyes the hair, minimal
      forms that go unnoticed by MEKAR retinopathies can be induced.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">December 19, 2019</start_date>
  <completion_date type="Anticipated">March 2021</completion_date>
  <primary_completion_date type="Anticipated">December 2020</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Diagnostic</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>% of patients with MEKAR retinopathy detected on OCT-B scan</measure>
    <time_frame>Day of inclusion, up to one month month after the last hair dye</time_frame>
    <description>Physiological parameter : Serous retinal detachment at the posterior pole, detected on OCT-B scan</description>
  </primary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">100</enrollment>
  <condition>MEK Inhibitor-Associated Serous Retinopathy</condition>
  <arm_group>
    <arm_group_label>Participants with hair dye</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Hair dye product with pPD Type Aromatic Amines used up to 1 month before</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>OCT-B scan</intervention_name>
    <description>OCT-B scan (Optical coherence tomography)</description>
    <arm_group_label>Participants with hair dye</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Hair dye up to one month before the inclusion

          -  Hair dye product containing aromatic amines

        Exclusion Criteria:

          -  Pregnant or lactating woman

          -  Retinal pathology already known, or central serous choroiditis
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Claire SCEMAMA, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>cstimsit@for.paris</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Am√©lie YAVCHITZ, MD</last_name>
    <phone>(0)148036454</phone>
    <phone_ext>+33</phone_ext>
    <email>ayavchitz@for.paris</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Martine MAUGET FAYSSE, MD</last_name>
    <phone>(0)148036440</phone>
    <phone_ext>+33</phone_ext>
    <email>mmfaysse@for.paris</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Fondation A de Rothschild</name>
      <address>
        <city>Paris</city>
        <zip>75019</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Claire SCEMAMA, MD</last_name>
      <email>ctimsit@for.paris</email>
    </contact>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>January 2020</verification_date>
  <study_first_submitted>December 11, 2019</study_first_submitted>
  <study_first_submitted_qc>January 7, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">January 10, 2020</study_first_posted>
  <last_update_submitted>January 7, 2020</last_update_submitted>
  <last_update_submitted_qc>January 7, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">January 10, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>MEK Inhibitor-Associated Serous Retinopathy</keyword>
  <keyword>Hair dye</keyword>
  <keyword>Aromatic amines</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Retinal Diseases</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

